This recording was originally a Rockwell Automation sponsored webinar presented live in conjunction with Progressive Media International.
The Life Sciences industry relies today on various frameworks and methods (QbD, PAT, CPV) to facilitate the development, analysis and monitoring of manufacturing processes. Yet, it takes 5-7 years to launch a new drug, with commercial production lead time averages of 120 to 180 days versus 3 to 7 days in the consumer goods industry, and biotech facilities continuing to experience a batch failure every 10 months.
This webinar reviews internal and external barriers to the full adoption of PAT, explores new approaches for the implementation of PAT and CPV, and identifies key capabilities that a unified data platform should have to facilitate the holistic and end-to-end quality by design approach promoted by the FDA.
If you have been leading PAT development and struggling to overcome internal and external barriers, dealing with batch performance challenges, and long process investigation lead times, this webinar will provide tangible guidance and solutions that you can implement in your organization to help you accelerate process development, gain batch performance visibility across your sites, and reduce process variability.
Key Takeaways:
- Understand the internal and external barriers for PAT implementation in commercial manufacturing
- Learn how to overcome the barriers and drive adoption in commercial manufacturing
- Understand how adopting PAT early and using a unified data platform approach can help accelerate process development, gain visibility across your operations and minimize process variability
